26 Einträge gefunden

1. The first steps towards a diverse and inclusive EBMT: a position paper.

   1. Montoto, S
   2. Snowden, J A
   3. Chabannon, C
   4. Corbacioglu, S
   5. de la Camara, R
   6. Dolstra, H
   7. Greco, R

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

   1. McLornan, D
   2. Eikema, D J
   3. Czerw, T
   4. Kröger, N
   5. Koster, L
   6. Reinhardt, Hans Christian
   7. Angelucci, E

   2021 - Forschungsinformationssystem des UKE
3. Third International workshop on the biology, prevention, and treatment of relapse after stem cell transplantation

   1. Kröger, N
   2. Bishop, M
   3. Giralt, S
   4. Wayne, A

   2018 - Forschungsinformationssystem des UKE
4. Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany

   1. Kuba, K
   2. Esser, P
   3. Mehnert, A
   4. Johansen, C
   5. Schwinn, A
   6. Schirmer, L
   7. Schulz-Kindermann, F

   2017 - Forschungsinformationssystem des UKE
5. The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis

   1. Ruutu, T
   2. Gratwohl, A
   3. Niederwieser, D
   4. de Witte, T
   5. van der Werf, S
   6. van Biezen, A
   7. Mohty, M

   2017 - Forschungsinformationssystem des UKE
6. Jon van Rood (1926-2017)

   1. Mueller, C
   2. Bonini, C
   3. Foeken, L
   4. Chabannon, C
   5. Bondanza, A
   6. Fleischhauer, K
   7. Velardi, A

   2017 - Forschungsinformationssystem des UKE
7. Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations

   1. Marchetti, M
   2. Barosi, G
   3. Cervantes, F
   4. Birgegård, G
   5. Griesshammer, M
   6. Harrison, C
   7. Hehlmann, R

   2017 - Forschungsinformationssystem des UKE
8. In search of the optimal platform for Post-Allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review

   1. Oostvogels, R
   2. Uniken Venema, S M
   3. de Witte, M
   4. Raymakers, R
   5. Kuball, J
   6. Kröger, N
   7. Minnema, M C

   2017 - Forschungsinformationssystem des UKE
9. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

   1. Passweg, J R
   2. Baldomero, H
   3. Bader, P
   4. Bonini, C
   5. Duarte, R F
   6. Dufour, C
   7. Gennery, A

   2017 - Forschungsinformationssystem des UKE
10. Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)

    1. Bug, G
    2. Burchert, A
    3. Wagner, E-M
    4. Kröger, N
    5. Berg, T
    6. Güller, S
    7. Metzelder, S K

    2017 - Forschungsinformationssystem des UKE
11. Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT

    1. Esser, Peter
    2. Kuba, Katharina
    3. Mehnert, A
    4. Schwinn, A
    5. Schirmer, L
    6. Schulz-Kindermann, F
    7. Kruse, Margitta

    2017 - Forschungsinformationssystem des UKE
12. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia-A randomized comparison of stem cell transplantation with drug treatment

    1. Gratwohl, A
    2. Pfirrmann, M
    3. Zander, A
    4. Kröger, N
    5. Beelen, D
    6. Novotny, J
    7. Nerl, C

    2016 - Forschungsinformationssystem des UKE
13. Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients

    1. Yousef, S
    2. Marvin, J
    3. Steinbach, M
    4. Langemo, A
    5. Kovacsovics, T
    6. Binder, M
    7. Kröger, N

    2015 - Forschungsinformationssystem des UKE
14. Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome

    1. Nagler, A
    2. Labopin, M
    3. Berger, R
    4. Bunjes, D
    5. Campos, A
    6. Socié, G
    7. Kröger, N

    2014 - Forschungsinformationssystem des UKE
15. JAK inhibition with ruxolitinib as pretreatment for allogeneic stem cell transplantation in primary or post-ET/PV myelofibrosis

    1. Stübig, T
    2. Alchalby, H
    3. Ditschkowski, M
    4. Wolf, D
    5. Wulf, G
    6. Zabelina, T
    7. Wolschke, C

    2014 - Forschungsinformationssystem des UKE
16. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT

    1. Sarkar, S
    2. Scherwath, A
    3. Schirmer, L
    4. Schulz-Kindermann, F
    5. Neumann, K
    6. Kruse, M
    7. Dinkel, A

    2014 - Forschungsinformationssystem des UKE
17. Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation

    1. Mohty, M
    2. Hübel, K
    3. Kröger, N
    4. Aljurf, M
    5. Apperley, J
    6. Basak, G W
    7. Bazarbachi, A

    2014 - Forschungsinformationssystem des UKE
18. Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4+ and CD8+ T-cell responses in multiple myeloma patients

    1. Reinhard, H
    2. Yousef, S
    3. Luetkens, T
    4. Fehse, B
    5. Berdien, B
    6. Kröger, N
    7. Atanackovic, D

    2014 - Forschungsinformationssystem des UKE - frei zugänglich
19. Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis

    1. Stern, M
    2. de Wreede, L C
    3. Brand, R
    4. van Biezen, A
    5. Dreger, P
    6. Mohty, M
    7. de Witte, T M

    2014 - Forschungsinformationssystem des UKE
20. Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma

    1. Atanackovic, D
    2. Luetkens, T
    3. Kröger, N

    2014 - Forschungsinformationssystem des UKE